Soluplus® – For better solubility and bioavailability

Did you know that Soluplus® also solubilizes drugs processed by wet granulation?
Try Soluplus® and experience a new dimension in solubility and bioavailability enhancement.

Soluplus® is an innovative excipient that enables new levels of solubility and bioavailability for poorly soluble active ingredients. Developed specifically for solid solutions, Soluplus® is unique in many ways. Thanks to its high flowability and excellent extrudability, Soluplus® shows superior performance in forming solid solutions, especially in hot melt extrusion processes. This solid solution makes the active pharmaceutical ingredient (API) available in a dissolved state, resulting in improved bioavailability, once in the body. The safety of Soluplus® is documented by a comprehensive range of toxicological data. Soluplus® has already been approved in Europe. Click to enlarge the poster

Overview poster of soluplus
Soluplus® – For better solubility and bioavailability

 

  • Soluplus® has been designed to solubilize poorly soluble APIs
  • Outstanding solubilization properties, especially for poorly soluble APIs
  • Enables bioavailability enhancement
  • Ideal for hot melt extrusion and all standard granulation techniques
  • Market proven solution for unique formulation challenges
  • Now approved in Europe

GET A SAMPLE

DOWNLOAD THE POSTER

 

 

More about BASF Pharmaceutical Excipients

You might also like